COSCIENS Biopharma (CSCI) had the highest return between December 1, 2023 and January 31, 2024 by a US stock, returning 2,343.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
COSCIENS Biopharma (CSCI) | 12/1/2023 - 1/31/2024 | 2,343.46% |
Diversified Energy (DEC) | 12/1/2023 - 1/31/2024 | 1,296.48% |
Rail Vision Ltd Ordinary Share (RVSN) | 12/1/2023 - 1/31/2024 | 1,207.02% |
Zivo Bioscience (ZIVO) | 12/1/2023 - 1/31/2024 | 1,205.41% |
JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL) | 12/1/2023 - 1/31/2024 | 1,005.65% |
Mobix Labs (MOBXW) | 12/1/2023 - 1/31/2024 | 888.14% |
Spring Valley Acquisition Corp II Rights (SVIIR) | 12/1/2023 - 1/31/2024 | 596.52% |
Shattuck Labs (STTK) | 12/1/2023 - 1/31/2024 | 421.55% |
Celularity (CELUW) | 12/1/2023 - 1/31/2024 | 419.67% |
Swvl (SWVL) | 12/1/2023 - 1/31/2024 | 416.13% |
Rail Vision Ltd Warrant (RVSNW) | 12/1/2023 - 1/31/2024 | 344.84% |
Fold Holdings, Inc Warrant (FLDDW) | 12/1/2023 - 1/31/2024 | 344.44% |
Eyepoint Pharmaceuticals (EYPT) | 12/1/2023 - 1/31/2024 | 334.35% |
Corbus Pharmaceuticals (CRBP) | 12/1/2023 - 1/31/2024 | 307.54% |
NewAmsterdam Pharma Company NV Warrant (NAMSW) | 12/1/2023 - 1/31/2024 | 299.57% |
C4 Therapeutics (CCCC) | 12/1/2023 - 1/31/2024 | 286.25% |
Sezzle (SEZL) | 12/1/2023 - 1/31/2024 | 280.28% |
Osisko Development Corp Warrant expiring 5/27/2027 (ODVWZ) | 12/1/2023 - 1/31/2024 | 277.36% |
error (ZVZZT) | 12/1/2023 - 1/31/2024 | 272.76% |
CCSC Technology International Holdings Limited Ordinary Shares (CCTG) | 12/1/2023 - 1/31/2024 | 268.52% |
Sera Prognostics (SERA) | 12/1/2023 - 1/31/2024 | 268.42% |
Compugen (CGEN) | 12/1/2023 - 1/31/2024 | 265.15% |
Cadrenal Therapeutics, Inc Common Stock (CVKD) | 12/1/2023 - 1/31/2024 | 264% |
QXO (QXO) | 12/1/2023 - 1/31/2024 | 261.69% |
ADC Therapeutics (ADCT) | 12/1/2023 - 1/31/2024 | 257.8% |
